Ashwagandha

Ashwagandha extract

Products
323
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 320 labeled products
Min
2 mg
Typical
230.778 mg
Max
1.8 g
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Products with avoid-level excipients
18

contain Ashwagandha extract AND at least one authority-avoid-flagged excipient

Products with caution-level excipients
1

contain Ashwagandha extract alongside a caution-flagged filler

Top brands carrying Ashwagandha extract

15 brands rolled up

Products containing Ashwagandha extract

323 in catalog